Form 4: Medtronic CEO Geoffrey Martha's Tax-Related Stock Sale

Medtronic plc's Chairman and CEO, Geoffrey Martha, reported a disposition of 1,564 ordinary shares for tax purposes related to restricted stock unit vesting.

Summary

• Geoffrey Martha, Chairman and CEO of Medtronic plc, disposed of 1,564 ordinary shares.
• The transaction occurred on December 15, 2025, at a price of $99.87 per share.
• These shares were withheld for the payment of taxes upon the vesting of restricted stock units.
• The vesting was triggered by the reporting person's retirement eligibility.
• Following this transaction, Martha beneficially owns 246,393 ordinary shares.
• This total includes 832 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction (tax withholding) related to executive compensation, which is neutral in terms of company performance or strategic direction.

Positives

• The reporting person's beneficial ownership remains substantial at 246,393 shares, indicating continued alignment with shareholder interests.
• The acquisition of 832 shares through dividend reinvestment demonstrates ongoing participation in the company's equity.

Negatives

• A disposition of shares, even for tax purposes, reduces the direct equity holding of the CEO.

Future Outlook

NA

Industry Context

This routine insider transaction, a tax-related disposition of shares, is specific to Medtronic's CEO and does not reflect broader industry trends or competitive dynamics within the medical technology sector.

Comparison to Industry Standards

• Routine insider transactions like tax withholdings are standard practice across industries and do not typically warrant specific comparisons to other companies' operational or financial results.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary tax-related transaction by an executive.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Medtronic, MDT, Geoffrey Martha, SEC Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, Director